Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease

Shapiro S. D.

Source: Eur Respir J 2007; 29: 375-378
Journal Issue: February
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Shapiro S. D.. Transgenic and gene-targeted mice as models for chronic obstructive pulmonary disease. Eur Respir J 2007; 29: 375-378

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

SEWQ ZAV - 20.09.2021 12:32
I have recently been told I have COPD/emphysema due to smoking. A few years back my general physician said there was something showing on my lungs. Thanks To World Herbs Clinic, Their Emphysema/COPD herbal supplement is nothing less than a miracle, I am fully back on my feet again and strong!. 
You must Login to comment this presentation.


Related content which might interest you:
Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013

Cigarette smoke induced pulmonary emphysema is attenuated in CCR6 deficient mice
Source: Annual Congress 2006 - Cell biology of asthma and COPD
Year: 2006


Elastin expression in very severe human COPD
Source: Eur Respir J 2009; 33: 324-331
Year: 2009



Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013

Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


TNF and LTA genes and susceptibility to chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004

Model of staged development chronic obstructive pulmonary disease (COPD) in rats
Source: Annual Congress 2011 - Novel mechanisms in lung injury
Year: 2011


Longterm NO2-exposure induces pulmonary inflammation and progressive development of airflow obstruction in C57BL/6 mice
Source: Eur Respir J 2003; 22: Suppl. 45, 196s
Year: 2003

Screening for α1-Pi deficiency in patients with lung diseases
Source: Eur Respir J 2002; 20: 319-324
Year: 2002



Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005


Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres
Source: Eur Respir J 2010; 35: 960-968
Year: 2010



Enhanced expression of IL-18 receptor but not soluble form of IL18R in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011

Inferon administration to patients with chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009

Nintedanib has acute pulmonary vasodilatory effects in transgenic Fra2 mice with spontaneous progressive pulmonary hypertension and lung fibrosis.
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019

Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients
Source: Eur Respir J 2008; 32: 372-378
Year: 2008



Desmosin as a marker for tissue injury in COPD
Source: Annual Congress 2007 - α1-Antitrypsin deficiency: molecular and clinical news
Year: 2007


Interleukin-18 production and pulmonary function in COPD
Source: Eur Respir J 2008; 31: 287-297
Year: 2008



Circulating tumor cells in chronic obstructive pulmonary disease patients
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011



Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013